|
2
Votes
vote
EGFR-targeted therapy improves survival rates in metastatic colorectal cancer patientsMerck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) demonstrated a significant improvement in overall survival (OS) when added to standard 1st-line chemotherapy for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors. ... |
|
2
Votes
vote
Switching early breast cancer patients to exemestane improves long-term survivalBerlin, Germany: New research has found that switching post-menopausal women with early breast cancer to the drug exemestane (Aromasin) after two or three years of tamoxifen rather than keeping them on tamoxifen for five years improves the chance of remaining cancer free and reduces the risk of deat ... |
admissions-application
advances-in-technology
alice
american-singer
application-source
bucs-game
canada
choices
chrisette-michelle
christmas
christmas-giveaway
downloads
e-mail
education
elements
flowers
greatest-hits
hall-of-fame
hallmark-hall-of-fame
india
ipod-mini
knee-injury
match
money
new-england
new-england-patriots
new-orleans-saints
new-photos
nfl-star
performance
united-kingdom
united-states
Get Keegy on your site
Put Keegy everywhere
Add buttons to know your online users , ranking position o your visitors vote your stories.
